Notícias

Microsoft's recent Azure strength may not tell the full story

The milestone raises the bar for AMD's next phase

Cognex (NASDAQ:CGNX) said it has entered into a definitive agreement to acquire RealSense, a provider of depth-sensing cameras and vision technology used in robotic perception and physical AI applications. The transaction is intended to expand Cognex’s machine-vision portfolio into 3D depth percept

Compass Therapeutics, Inc. (NASDAQ:CMPX) shares are trading lower on Tuesday as the FDA feedback raises new questions about the timing and requirements for its tovecimig program. The move is coming even as S&P 500 futures are up 0.1%, pointing to stock-specific pressure rather than a broad risk-off tape. Read Also: Compass Therapeutics' Bile Duct Cancer Drug Seen As New Standard Of Care CMPX Stock Drops After FDA Feedback On Tovecimig BLA Path Compass said the FDA recommended the company run a t

Energy stocks traded mixed Tuesday afternoon, with the NYSE Energy Sector Index up 0.3% and the Stat

Wall Street has targets for Google, NVIDIA, and Salesforce, but one analyst thinks those numbers still leave serious money on the table heading into 2027. Here is the math behind three bold calls that could reshape how you size your tech positions.

AI companies have competed on having the best and often most dangerous models for years. Now, they're pivoting to a new focus: cost.

(Updates with index/price moves, macroeconomic data, and comments from the first paragraph.) US e

Dutch Bros Inc (NYSE:BROS) shares have fallen 37% since the coffee chain's second-quarter results, but Bank of America (BofA) says the stock's valuation remains attractive and has reiterated its 'buy' rating. The analyst says concerns over near-term same-store sales and longer-term...

Skyward Specialty Insurance has had an impressive run over the past six months as its shares have beaten the S&P 500 by 17.7%. The stock now trades at $57.18, marking a 33.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Apple (AAPL) stock hit a record high on Tuesday, driven by the latest fanfare over its foldable iPhone Duo. Today's Market Hang panel consists of Host Turney Duff, Yahoo Finance Executive Editor Brian Sozzi, Defiance ETFs CIO Sylvia Jablonski, Interactive Brokers chief strategist Steve Sosnick, and Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber.

Pinterest keeps sliding lower while its closest peers barely flinch, and no news has surfaced to explain the gap. Something is moving inside Pinterest's shareholder base, and the pattern is getting harder to ignore.

(Updates with latest market prices and developments.) US benchmark equity indexes were mixed intr

Financial stocks were lower in Tuesday afternoon trading, with the NYSE Financial Index falling 1.5%

Key TakeawaysNebius’s reported EBITDA margin swung from negative 24. 33% in Q4 2025 to 21.

Public investors will now test AI drug-discovery enthusiasm

When management takes the stage in New York, demand from an unexpected source could change how Wall Street prices the stock.

One key rate move sits behind the bullish forecast

Spotify's Q2 gross margin rose to 33.4% as Premium growth outpaced music costs and Ad-Supported gains lifted operating profitability.

Investor expectations have become concentrated at unprecedented scale

A policy shift could finally move quantum beyond research

The 1,156 transactions in July totaled between roughly $79 million and $270 million, according to a CNBC analysis

Tight supply could keep pricing power stronger for longer

Over the last six months, S&P Global’s shares have sunk to $405.30, producing a disappointing 5.5% loss - a stark contrast to the S&P 500’s 16.2% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

In an interview with CNBC, Ives said Meta’s roughly 3.5 billion users across its platforms give it a significant existing audience for consumer AI products.

Circle sells Binance $100M in discounted CRCL shares as the pair expand their USDC deal.

Moderna (MRNA) stock rose roughly 510% over the year to September 21, 2026, climbing from about $25 to about $173. The S&P 500 gained 18.5% with dividends reinvested over the same window, and Pfizer (PFE) about 23%. The run's central event came on August 19, 2026, when Merck and Moderna said a Phase III trial of their cancer vaccine, intismeran autogene, met its endpoints in melanoma. A rough timetable for the trial was public long before the stock moved, but its result was not.

Should investors bet more on the AI infrastructure bottlenecks than on other tech trends, such as social media? Today's Market Hang panel consists of Host Turney Duff, Yahoo Finance Executive Editor Brian Sozzi, Defiance ETFs CIO Sylvia Jablonski, Interactive Brokers chief strategist Steve Sosnick, and Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber.

Tech stocks advanced Tuesday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK

Consumer stocks advanced Tuesday afternoon, with the State Street Consumer Staples Select Sector SPD